| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |